Containment Dermatology Licensing 
The Pharma Data
OCTOBER 29, 2020
30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today new data for baricitinib (marketed as OLUMIANT ® ) will be presented at the annual Fall Clinical Dermatology meeting taking place virtually October 29-November 1, 2020. INDIANAPOLIS , Oct. Skin-related diseases are more than skin deep.
Druggist
DECEMBER 9, 2020
Lotions: contain the least amount of oils and higher amounts of water with non-greasy consistency. Clobetasone has a narrow licensed use. It contains a combination of miconazole (an antifungal drug) and hydrocortisone 1% (steroid). Creams: optimal amount of oil vs water, but in higher oil amounts than lotions. Chickenpox.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
MARCH 17, 2021
Although licensed for acne, minocycline is rarely prescribed in the UK. Freederm gel contains Vitamin B complex (Nicotinamide) which reduces spot size, redness and inflammation. Strauss JS, Krowchuk DP, Leyden JJ, American Academy of Dermatology/American Academy of Dermatology Association, et al. J Am Acad Dermatol.
Druggist
OCTOBER 25, 2020
Calamine lotion available in the UK for management of chickenpox symptoms contain a mixture of calamine (15%) and zinc oxide (5%). Nevertheless, calamine lotion is licensed in the UK for symptomatic relief of skin conditions including itchiness. Creams contain higher amounts of oil(s), and therefore are of thicker consistency.
The Pharma Data
JANUARY 13, 2021
(IPIX) is a clinical stage biopharmaceutical company developing a world-class portfolio of innovative therapies addressing multiple areas of unmet medical need, including inflammatory diseases, cancer, infectious diseases, and dermatologic diseases. Brilacidin for UP/UPS was licensed to Alfasigma S.p.A.
The Pharma Data
AUGUST 17, 2021
Mismatch repair-deficient tumours contain abnormalities that affect the proper repair of DNA when copied in a cell [i]. JEMPERLI was discovered by AnaptysBio and licensed to TESARO, Inc., under a Collaboration and Exclusive License Agreement signed in March 2014.
The Pharma Data
JANUARY 24, 2021
VP-102 is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidim delivered by way of a single-use applicator. The drug was well tolerated and demonstrated clinically meaningful improvement in the Dermatology Life Quality Index (DLQI) and Patient-Oriented Eczema Measure IPOEM).
Expert insights. Personalized for you.
52 
Let's personalize your content